An Observational Study of Combination of Pegylated Liposomal Doxorubicin and Trabectedin in Routine Practice in Patients With Recurrent Partial-platinum Sensitive Ovarian Cancer
Clinical trial NCT03446495 · UNKNOWN
Trial details
- NCT number
- NCT03446495
- Sponsor
- Suriya Yessentayeva
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-03-28
- Primary completion
- 2019-03-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.